Cargando…
Chemical Synthesis of the PAX Protein Inhibitor EG1 and Its Ability to Slow the Growth of Human Colorectal Carcinoma Cells
Colorectal cancer is primarily a disease of the developed world. The incidence rate has continued to increase over time, reflecting both demographic and lifestyle changes, which have resulted in genomic and epigenomic modifications. Many of the epigenetic modifications occur in genes known to be clo...
Autores principales: | McDougall, Lorissa, Kueh, Jui Thiang Brian, Ward, Jake, Tyndall, Joel D. A., Woolley, Adele G., Mehta, Sunali, Stayner, Cherie, Larsen, David S., Eccles, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549845/ https://www.ncbi.nlm.nih.gov/pubmed/34722257 http://dx.doi.org/10.3389/fonc.2021.709540 |
Ejemplares similares
-
SMAD proteins directly suppress PAX2 transcription downstream of transforming growth factor-beta 1 (TGF-β1) signalling in renal cell carcinoma
por: Kaur, Gagandeep, et al.
Publicado: (2018) -
Polycystic kidney disease – where gene dosage counts
por: Eccles, Michael R., et al.
Publicado: (2014) -
Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease
por: Zheng, Qi, et al.
Publicado: (2022) -
Norborn-2-en-7-ones as physiologically-triggered carbon monoxide-releasing prodrugs
por: Kueh, Jui Thiang Brian, et al.
Publicado: (2017) -
PAX Genes in Cancer; Friends or Foes?
por: Li, Caiyun G., et al.
Publicado: (2012)